{"layout":"Indicator","sdg_goal":"3","goal_number":"3","indicator_number":"3.d.2","indicator_sort_order":"03-dd-02","permalink":"/3-d-2/","reporting_status":"complete","published":true,"data_non_statistical":false,"national_indicator_available":"Percentage of bloodstream infections due to selected antimicrobial-resistant organisms","comparison_sdg":null,"goal_meta_national_link":"https://SdgTestEnvironment.github.io/sdg-indicators/public/MetaDe/3.d.2.pdf","goal_meta_national_link_text":"National metadata","indicator_name":"Percentage of bloodstream infections due to selected antimicrobial-resistant organisms","target_name":"Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks","target_id":"3.d","un_designated_tier":"<a href=\"https://unstats.un.org/sdgs/iaeg-sdgs/tier-classification/\" title=\"Click here for more information on the UN tier classification.\"  target=\"_blank\">Tier II</a>","un_custodian_agency":null,"goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0d-02.pdf","goal_meta_link_text":"United Nations Sustainable Development Goals Metadata","source_active_1":true,"source_organisation_1":"World Health Organization (WHO)","source_organisation_logo_1":"<a href=\"https://www.who.int/en\"><img src=\"https://g205sdgs.github.io/sdg-indicators/public/OrgImgEn/who.png\" alt=\"Logo who\" style=\"height:60px; width:148px\" /></a>","source_url_1":"https://apps.who.int/gho/tableau-public/tpc-frame.jsp?id=2012","source_url_text_1":"GLASS Country, territory and area profiles, 2018","source_active_2":false,"source_active_3":false,"source_active_4":false,"source_active_5":false,"source_active_6":false,"data_keywords":null,"data_show_map":false,"data_start_values":[{"field":"Antimicrobial-resistant organism","value":"Escherichia coli with resistance to 3rd generation cephalosporins (e.g. ESBL- E. coli)"},{"field":"Antimicrobial-resistant organism","value":"Methicillin-resistant Staphylococcus aureus (MRSA)"},{"field":"Data source","value":"European Centre for Disease Prevention and Control"},{"field":"Data source","value":"World Health Organization (WHO)"}],"computation_units":"Percentage","copyright":"&copy; Federal Statistical Office (Destatis), 2021","data_footnote":"Patients seeking care and whose blood sample is taken and tested.","graph_title":"Percentage of bloodstream infections due to selected antimicrobial-resistant organisms","graph_type":"line","show_line":true,"span_gaps":true,"precision":[{"decimals":2}],"previous":"3-d-1","next":"4-1-1","national_geographical_coverage":null,"page_content":"\n<span></span>","national_metadata_update_url_text":"2021-04-15: see changes on GitHub","national_metadata_update_url":"https://github.com/SdgTestEnvironment/sdg-data/commit/a1f0bcae97e6422f6cd8a5bf3cf9e6491c4fc999","national_data_update_url_text":"2021-04-15: see changes on GitHub","national_data_update_url":"https://github.com/SdgTestEnvironment/sdg-data/commit/a1f0bcae97e6422f6cd8a5bf3cf9e6491c4fc999","indicator":"3.d.2","language":"en","goal_meta_2_link_text":null,"goal_meta_3_link_text":null}